Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $50.88 in the prior trading day, Bruker Corp (NASDAQ: BRKR) closed at $49.14, down -3.42%. In other words, the price has decreased by -$3.42 from its previous closing price. On the day, 3.0 million shares were traded. BRKR stock price reached its highest trading level at $50.685 during the session, while it also had its lowest trading level at $48.74.
Ratios:
Our goal is to gain a better understanding of BRKR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.82.
On December 09, 2025, Goldman started tracking the stock assigning a Sell rating and target price of $40.
On November 20, 2025, Rothschild & Co Redburn started tracking the stock assigning a Buy rating and target price of $60.Rothschild & Co Redburn initiated its Buy rating on November 20, 2025, with a $60 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 12 ’26 when Munch Mark sold 7,000 shares for $55.00 per share. The transaction valued at 385,000 led to the insider holds 128,443 shares of the business.
MARK R MUNCH bought 7,000 shares of BRKR for $385,000 on Jan 12 ’26. On Jan 05 ’26, another insider, Munch Mark, who serves as the EXEC VP&PRES BRUKER NANO INC. of the company, sold 33,843 shares for $49.66 each. As a result, the insider received 1,680,647 and left with 128,443 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 7466387968 and an Enterprise Value of 9281288192. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 45.71. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.17 while its Price-to-Book (P/B) ratio in mrq is 3.06. Its current Enterprise Value per Revenue stands at 2.699 whereas that against EBITDA is 15.865.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.19, which has changed by -0.13777328 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $63.95, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 6.03%, while the 200-Day Moving Average is calculated to be 24.61%.
Shares Statistics:
The stock has traded on average 2.49M shares per day over the past 3-months and 2554080 shares per day over the last 10 days, according to various share statistics. A total of 151.39M shares are outstanding, with a floating share count of 103.19M. Insiders hold about 32.08% of the company’s shares, while institutions hold 89.07% stake in the company. Shares short for BRKR as of 1767139200 were 10614432 with a Short Ratio of 4.27, compared to 1764288000 on 13704909. Therefore, it implies a Short% of Shares Outstanding of 10614432 and a Short% of Float of 15.040000000000001.
Dividends & Splits
In the trailing 12 months, BRKR’s forward annual dividend rate was 0.2, compared to 0.20 this year. Against a Trailing Annual Dividend Yield of 0.0039308174. The stock’s 5-year Average Dividend Yield is 0.32.
Earnings Estimates
Currently, 13.0 analysts are dedicated to thoroughly evaluating and rating the performance of Bruker Corp (BRKR) in the stock market.The consensus estimate for the next quarter is $0.42, with high estimates of $0.61 and low estimates of $0.27.
Analysts are recommending an EPS of between $1.9 and $1.85 for the fiscal current year, implying an average EPS of $1.88. EPS for the following year is $2.15, with 15.0 analysts recommending between $2.44 and $2.06.
Revenue Estimates
12 analysts predict $958.3M in revenue. The current quarter. It ranges from a high estimate of $966.5M to a low estimate of $952.51M. As of. The current estimate, Bruker Corp’s year-ago sales were $979.6MFor the next quarter, 12 analysts are estimating revenue of $803.82M. There is a high estimate of $828.43M for the next quarter, whereas the lowest estimate is $770M.
A total of 13 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.43B, while the lowest revenue estimate was $3.41B, resulting in an average revenue estimate of $3.42B. In the same quarter a year ago, actual revenue was $3.37BBased on 13 analysts’ estimates, the company’s revenue will be $3.47B in the next fiscal year. The high estimate is $3.55B and the low estimate is $3.43B.
